William Blair Investment Management LLC Has $15.43 Million Stock Position in Sotera Health (NASDAQ:SHC)

William Blair Investment Management LLC reduced its position in Sotera Health (NASDAQ:SHC) by 0.1% in the 4th quarter, HoldingsChannel reports. The firm owned 1,127,583 shares of the company’s stock after selling 864 shares during the period. William Blair Investment Management LLC’s holdings in Sotera Health were worth $15,425,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in the business. Blue Trust Inc. increased its holdings in shares of Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock valued at $25,000 after purchasing an additional 1,140 shares during the last quarter. True Wealth Design LLC acquired a new position in Sotera Health in the 3rd quarter valued at about $32,000. GAMMA Investing LLC grew its stake in Sotera Health by 37.5% in the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock valued at $56,000 after buying an additional 1,121 shares during the last quarter. PNC Financial Services Group Inc. grew its position in shares of Sotera Health by 39.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company’s stock valued at $127,000 after purchasing an additional 2,627 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its position in shares of Sotera Health by 17.3% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company’s stock valued at $217,000 after purchasing an additional 2,340 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Stock Up 2.1 %

Shares of NASDAQ SHC opened at $12.24 on Thursday. The stock has a market capitalization of $3.47 billion, a P/E ratio of 48.96 and a beta of 1.92. The stock’s fifty day moving average is $12.99 and its 200 day moving average is $14.19. Sotera Health has a 52 week low of $10.71 and a 52 week high of $17.08. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88.

Analysts Set New Price Targets

SHC has been the topic of a number of research reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a report on Thursday, November 21st. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a research note on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target on the stock. Finally, Barclays decreased their price target on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a research note on Friday, February 28th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $15.92.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.